|
ZNF318 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.71080000166413E-08 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.55320000042536E-07 |
| Normal-vs-Stage2 |
2.824600E-03 |
| Normal-vs-Stage3 |
1.11980003048018E-09 |
| Normal-vs-Stage4 |
1.48229999996641E-06 |
| Stage1-vs-Stage2 |
4.543800E-01 |
| Stage1-vs-Stage3 |
3.833600E-02 |
| Stage1-vs-Stage4 |
4.237600E-01 |
| Stage2-vs-Stage3 |
3.564100E-02 |
| Stage2-vs-Stage4 |
2.213000E-01 |
| Stage3-vs-Stage4 |
4.417000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.39689999462323E-08 |
| Normal-vs-AfricanAmerican |
3.941600E-03 |
| Normal-vs-Asian |
3.20700000000507E-07 |
| Caucasian-vs-AfricanAmerican |
5.124200E-01 |
| Caucasian-vs-Asian |
4.488800E-01 |
| AfricanAmerican-vs-Asian |
2.440200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.2975999980932E-08 |
| Normal-vs-Female |
1.16339999967074E-07 |
| Male-vs-Female |
6.285000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.07309999997085E-06 |
| Normal-vs-Age(41-60Yrs) |
5.15820000046574E-07 |
| Normal-vs-Age(61-80Yrs) |
1.58440000008753E-07 |
| Normal-vs-Age(81-100Yrs) |
6.384500E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.145000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.846000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.789770E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.156800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.066000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.381000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.186840E-04 |
| Classical-VS-Follicular |
1.612430E-01 |
| Classical-VS-Other |
1.788970E-01 |
| Classical-VS-Normal |
1.67500000003429E-06 |
| Tall-VS-Follicular |
2.952300E-02 |
| Tall-VS-Other |
8.336000E-01 |
| Tall-VS-Normal |
5.77230041542975E-10 |
| Follicular-VS-Other |
4.546000E-01 |
| Follicular-VS-Normal |
3.97900000004281E-06 |
| Other-VS-Normal |
2.903900E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.51950000026879E-07 |
| Normal-vs-N1 |
6.44590000042911E-07 |
| N0-vs-N1 |
3.422800E-01 |
|
|
